CA2879824A1 - Sels de saxagliptine - Google Patents
Sels de saxagliptine Download PDFInfo
- Publication number
- CA2879824A1 CA2879824A1 CA2879824A CA2879824A CA2879824A1 CA 2879824 A1 CA2879824 A1 CA 2879824A1 CA 2879824 A CA2879824 A CA 2879824A CA 2879824 A CA2879824 A CA 2879824A CA 2879824 A1 CA2879824 A1 CA 2879824A1
- Authority
- CA
- Canada
- Prior art keywords
- saxagliptin
- acetate
- process according
- bicarbonate
- bisulphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2061DE2012 | 2012-07-02 | ||
IN2061/DEL/2012 | 2012-07-02 | ||
IN3917DE2012 | 2012-12-19 | ||
IN3917/DEL/2012 | 2012-12-19 | ||
PCT/IB2013/055429 WO2014006569A2 (fr) | 2012-07-02 | 2013-07-02 | Sels de saxagliptine |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2879824A1 true CA2879824A1 (fr) | 2014-01-09 |
Family
ID=54193750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2879824A Abandoned CA2879824A1 (fr) | 2012-07-02 | 2013-07-02 | Sels de saxagliptine |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2867206A2 (fr) |
AU (1) | AU2013285078A1 (fr) |
CA (1) | CA2879824A1 (fr) |
SG (1) | SG11201408619WA (fr) |
WO (1) | WO2014006569A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013175297A1 (fr) | 2012-05-24 | 2013-11-28 | Apotex Pharmachem India Pvt. Ltd | Sels de saxagliptine avec des acides organiques |
WO2015166466A1 (fr) * | 2014-05-01 | 2015-11-05 | Sun Pharmaceutical Industries Limited | Forme cristalline d'acétate de saxagliptine |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6395767B2 (en) * | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
US7420079B2 (en) | 2002-12-09 | 2008-09-02 | Bristol-Myers Squibb Company | Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof |
TW200538122A (en) | 2004-03-31 | 2005-12-01 | Bristol Myers Squibb Co | Process for preparing a dipeptidyl peptidase Ⅳ inhibitor and intermediates employed therein |
US7741082B2 (en) | 2004-04-14 | 2010-06-22 | Bristol-Myers Squibb Company | Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor |
US7214702B2 (en) | 2004-05-25 | 2007-05-08 | Bristol-Myers Squibb Company | Process for producing a dipeptidyl peptidase IV inhibitor |
PE20090696A1 (es) * | 2007-04-20 | 2009-06-20 | Bristol Myers Squibb Co | Formas cristalinas de saxagliptina y procesos para preparar las mismas |
WO2010115974A1 (fr) | 2009-04-09 | 2010-10-14 | Sandoz Ag | Formes cristallines de la saxagliptine |
WO2012017029A1 (fr) * | 2010-08-06 | 2012-02-09 | Sandoz Ag | Nouveaux sels de saxagliptine comportant des diacides organiques |
WO2012017028A1 (fr) | 2010-08-06 | 2012-02-09 | Sandoz Ag | Nouveau composé cristallin comprenant de la saxagliptine et de l'acide phosphorique |
US8410288B2 (en) | 2010-10-04 | 2013-04-02 | Teva Pharmaceutical Industries Ltd. | Polymorphs of Saxagliptin hydrochloride and processes for preparing them |
CN102086172A (zh) * | 2011-01-13 | 2011-06-08 | 廖国超 | 沙格列汀的药用盐及其制备方法 |
-
2013
- 2013-07-02 WO PCT/IB2013/055429 patent/WO2014006569A2/fr active Application Filing
- 2013-07-02 CA CA2879824A patent/CA2879824A1/fr not_active Abandoned
- 2013-07-02 SG SG11201408619WA patent/SG11201408619WA/en unknown
- 2013-07-02 AU AU2013285078A patent/AU2013285078A1/en not_active Abandoned
- 2013-07-02 EP EP13762566.1A patent/EP2867206A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
SG11201408619WA (en) | 2015-01-29 |
WO2014006569A2 (fr) | 2014-01-09 |
EP2867206A2 (fr) | 2015-05-06 |
AU2013285078A1 (en) | 2015-01-29 |
WO2014006569A3 (fr) | 2014-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11753394B2 (en) | Synthesis of omecamtiv mecarbil | |
EP2609099A2 (fr) | Sitagliptine, sels et polymorphes de celle-ci | |
US10464906B2 (en) | Crystalline forms of a histone deacetylase inhibitor | |
JP2013525384A (ja) | ニトロイミダゾール系化合物、その製造方法および用途 | |
WO2018142327A1 (fr) | Sels d'oxalate de ténéligliptine et solvates de ceux-ci, intermédiaires, procédé de préparation | |
CA2879824A1 (fr) | Sels de saxagliptine | |
EP2860180A1 (fr) | Nouveaux sels gentisate d'inhibiteur de DPP-IV | |
US20150239909A1 (en) | Process for the preparation of (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one | |
EP1511717A1 (fr) | Forme cristalline de nateglinide | |
AU2012277403A1 (en) | Novel salts of sitagliptin | |
US20150329489A1 (en) | Saxagliptin salts | |
US20130123501A1 (en) | Process for the preparation of the compound osi-906 | |
US11434226B2 (en) | Salt and polymorph of benzopyrimidinone compound and pharmaceutical composition and use thereof | |
US20040181089A1 (en) | Polymorphic forms of nateglinide | |
WO2015092624A1 (fr) | Mono-oxalate de nilotinib et sa forme cristalline | |
EP1467964A1 (fr) | Formes polymorphes de nateglinide | |
US10793554B2 (en) | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone | |
CN111620875B (zh) | 咪唑并吡嗪类化合物的制备工艺 | |
EP3468968A1 (fr) | Formes solides de ceftolozane et procédés de préparation | |
CN116239491A (zh) | 一种西格列汀杂质化合物i及其制备方法 | |
WO2015166466A1 (fr) | Forme cristalline d'acétate de saxagliptine | |
CN112759545A (zh) | 3-(二甲氨基甲基)哌啶-4-醇类衍生物及其制备方法和药物用途 | |
WO2015114479A1 (fr) | Formes cristallines d'oxalate, d'adipate, de succinate, de phosphate, de sulphate, de fumaratetartrate, de nitrate et de borate de darapladib | |
WO2014118737A1 (fr) | Sels d'erlotinib | |
WO2014147641A2 (fr) | Sel de phosphate de sitagliptine et de ptérostilbène, son procédé de préparation et composition pharmaceutique en contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20141223 |
|
FZDE | Dead |
Effective date: 20170517 |